Why DexCom (DXCM) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
DexCom (DXCM) Stock Declines While Market Improves: Some Information for Investors
DexCom (DXCM) concluded the recent trading session at $127.12, signifying a -1.68% move from its prior day's close.
These 2 Growth Stocks Are Brilliant Buys for the New Year
The healthcare industry has long been a compelling space for investors to generate steady returns. DexCom is raking in profits from newly launched products, and its long-term growth story looks bri...
Dexcom (DXCM) Set to Solidify Its Business Throughout EMEA
Dexcom (DXCM), opening a new manufacturing facility in the West of Ireland, is expected to boost production of rtCGM sensors and create employment.
Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
DexCom (DXCM) Advances While Market Declines: Some Information for Investors
DexCom (DXCM) closed the most recent trading day at $125.45, moving +0.8% from the previous trading session.
Why DexCom (DXCM) Could Beat Earnings Estimates Again
DexCom (DXCM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Mid-Cap Stocks Poised for a Breakout in 2024
Important voices in the investment world predict that 2024 could be a very strong year for mid-cap stocks. Janus Henderson portfolio manager Brian Demain believes the outlook for mid caps looks fav...
DexCom (DXCM) Preliminary Q4 Revenues Ride on Sensor Demand
DexCom's (DXCM) revenue growth in the fourth quarter is likely to have been boosted by strong demand for its CGM sensors across the globe. It delivers robust revenue guidance for 2024.
Here's Why DexCom (DXCM) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
DexCom (DXCM) Exceeds Market Returns: Some Facts to Consider
DexCom (DXCM) closed at $123.98 in the latest trading session, marking a +1.76% move from the prior day.
5 MedTech Stocks Poised to Continue Their Winning Streaks in 2024
Stocks like DexCom Inc. (DXCM), Integer Holdings (ITGR), Penumbra (PEN), Haemonetics (HAE), Health Equity (HAE) and are likely to continue their strong performance in 2024.
DexCom (DXCM) Stock Falls Amid Market Uptick: What Investors Need to Know
In the closing of the recent trading day, DexCom (DXCM) stood at $122.17, denoting a -0.51% change from the preceding trading day.
3 Reasons Why Growth Investors Shouldn't Overlook DexCom (DXCM)
DexCom (DXCM) is well positioned to outperform the market, as it exhibits above-average growth in financials.
DexCom's (DXCM) G7 CGM Connects With Tandem's Insulin Pump
Dexcom's (DXCM) G7 integrates with Tandem's t:slim X2, revolutionizing diabetes care. A perfect combination of accuracy and innovation, this synergy sets a new standard in continuous glucose monito...
Related Companies